In vivo Study of a Newly Synthesized Chromen-4-one Derivative as an Antitumor Agent against HCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo Study of a Newly Synthesized Chromen-4-one Derivative as an Antitumor Agent against HCC

Published:2021-10-26 Issue: Volume: Page:
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Nabeel Asmaa I.,Mansour Somaya Z.,Mahdy El-Sayed M. E.,El-Mezayen Hatem A.,Mohamed Sarah A.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s12029-021-00724-9.pdf

Reference55 articles.

1. Liu GB, Xu JL, Geng M, Xu R, Hui RR, Zhao JW, Xu Q, Xu HX, Li JX. Synthesis of a novel series of diphenolic chromone derivatives as inhibitors of NO production in LPS-activated RAW264. 7 macrophages. Bioorg Med Chem. 2010;18(8):2864-71.

2. Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health Syst Pharm. 2013;70(12):1025-32.

3. Shebl M, Saif M, Nabeel AI, Shokry R, New A, non-toxic transition metal nanocomplexes and Zn complex-silica xerogelnanohybrid: synthesis, spectral studies, antibacterial and antitumor activities. J Mol Struct. 2016;1118:335–43.

4. Elshawi OE, Nabeel AI. Modulatory effect of a new benzopyran derivative via COX-2 blocking and down regulation of NF-κB against γ-radiation induced-intestinal inflammation. J Photochem Photobiol. 2019;192:90-6.

5. Trinchieri, G, Cancer immunity: lessons from infectious diseases. J Infect Dis. 2015;212:S67–73.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights;Drug Development Research;2024-07

2. Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition;Drug Development Research;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3